An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma

HIGHLIGHTS

• who: Ninghua Yao from the (UNIVERSITY) have published the article: An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma, in the Journal: (JOURNAL)
• what: The authors identified and validated a robust IGS through multi-step processes using multiple databases (Fig 8).
• how: The authors developed and validated a robust risk model for HCC which could predict the prognosis of HCC patients and the response of immunotherapy. The authors compared the performance of the IGS risk model with 4 previous immune-related signatures in the CHCC cohort. The result . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.